Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Advances in understanding sepsis.

M Shimaoka¹, E J Park

¹Harvard Medical School, The CBR Institute for Biomedical Research, Department of Anesthesia, Boston, MA02115, USA. shimaoka@cbrinstitute.org

European Journal of Anaesthesiology. Supplement

|April 17, 2008

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Mask-induced dermatoses during the COVID-19 pandemic: a questionnaire-based study in 12 Korean hospitals.

Clinical and experimental dermatology·2021

Same author

Investigation of photodarkening in tandem-pumped Yb-doped fibers.

Optics express·2020

Same author

Therapeutic effects of kefir grain Lactobacillus-derived extracellular vesicles in mice with 2,4,6-trinitrobenzene sulfonic acid-induced inflammatory bowel disease.

Journal of dairy science·2018

Same author

Development of immune and microbial environments is independently regulated in the mammary gland.

Mucosal immunology·2018

Same author

Retinoblastoma protein (Rb) links hypoxia to altered mechanical properties in cancer cells as measured by an optical tweezer.

Scientific reports·2017

Same author

Critical role of TSLP-responsive mucosal dendritic cells in the induction of nasal antigen-specific IgA response.

Mucosal immunology·2016

Same journal

EuroNeuro 2010. Abstracts of the 6th EuroNeuro Congress. Porto, Portugal. February 4-6, 2010.

European journal of anaesthesiology. Supplement·2010

Same journal

Euroanaesthesia 2003. Abstracts of the joint meeting of the European Society of Anaesthesiologists and European Academy of Anaesthesiology, Confederation of European National Societies of Anaesthesiology, and Association of Anaesthetists of Great Britain & Ireland. May 31-June 3, 2003. Glasgow, Scotland.

European journal of anaesthesiology. Supplement·2008

Same journal

Evoked potentials in the ICU.

European journal of anaesthesiology. Supplement·2008

Same journal

Intracranial pressure monitoring.

European journal of anaesthesiology. Supplement·2008

Same journal

Phrenic nerve stimulation.

European journal of anaesthesiology. Supplement·2008

Same journal

Direct stimulation: a useful technique.

European journal of anaesthesiology. Supplement·2008

See all related articles

Sepsis involves a biphasic inflammatory response and coagulation issues. Novel therapies targeting late-phase mediators, apoptosis, and the vagus nerve show promise in improving sepsis survival.

Area of Science:

Critical Care Medicine
Immunology
Pathophysiology

Background:

Sepsis is a major cause of death in intensive care units, characterized by a complex inflammatory response.
The pathogenesis of sepsis involves a biphasic inflammatory process with both pro-inflammatory and anti-inflammatory mediators.
Aberrant activation of coagulation cascades complicates sepsis progression, contributing to treatment failures.

Purpose of the Study:

To review recent investigations into sepsis pathogenesis and novel therapeutic strategies.
To highlight the limitations of targeting only early pro-inflammatory cytokines in sepsis treatment.
To explore emerging interventions including activated protein C, high-mobility group box 1 inhibition, apoptosis suppression, and vagus nerve stimulation.

Main Methods:

Related Experiment Videos

Review of recent scientific literature on sepsis pathogenesis and treatment.
Analysis of pre-clinical and clinical data on novel sepsis interventions.
Examination of molecular medicine advances in understanding sepsis pathways.

Main Results:

Activated protein C improves survival by modulating inflammatory and coagulatory pathways.
Inhibition of high-mobility group box 1 demonstrates survival benefits in established sepsis models.
Suppression of lymphocyte apoptosis and vagus nerve stimulation show promise in ameliorating sepsis outcomes.

Conclusions:

Understanding the biphasic inflammatory response and coagulation dysregulation is crucial for effective sepsis treatment.
Targeting late-phase mediators like high-mobility group box 1 offers a potential therapeutic avenue.
Novel approaches such as apoptosis suppression and vagus nerve modulation represent promising future directions for sepsis management.